Recent observations indicate that alternative splicing is a common way for eukaryotes to expand their repertoire of gene functions. Studies indicate that approximately 50 percent of human genes exhibit alternative splicing and approximately 15 percent of disease-causing mutations involve aberrant alternative splicing. Different tissues show remarkably different frequencies of alternative splicing, with the brain accounting for approximately 18 percent of such events [Xu et al. (2002). Nucl. Acids Res. 30:3754–3766].

Why might some tissues engage in more alternative splicing than others?

Video transcript

Hello, everyone and welcome to today's video. So this revelation of alternative pricing is implicated in which of the following diseases. Well, all of these diseases are presented are going to be related or implicated with this regulation of alter placing in specific genes. So for example, Alzheimer's disease is implicated with the A PP TAU and certain other genes. My is going to be implicated with AC TL A four gene as well as others. And then we have Parkinson's which is implicated with the part two gene, the map T gene and many others. So this regulation of alternative pricing is actually present in all three of the diseases presented in this question because of this, the correct answer choice is going to be answer choice. I really hope this video helped you and I hope to see you on the next one.